Physician profile
Michael P Sullivan
NPI 1548269038
$1,323.65
in general payments reported to CMS, 2019-2025
19 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $45.52 · 2021: $57.10 · 2022: $135 · 2023: $74.52 · 2024: $386 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $780.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $276.43 | 2019-2022 | |
| Amgen INC. | $203.99 | 2024-2025 | Evenity, Prolia, Prolia |
| Abbott Laboratories | $161.41 | 2024 | Freestyle Libre 3 |
| Organon LLC | $137.09 | 2023-2025 | Jada System, Nexplanon |
| Pfizer INC. | $70.26 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $68.09 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $60.93 | 2022-2025 | |
| Ethicon US, LLC | $47.20 | 2019-2022 | |
| Myovant Sciences INC. | $45.42 | 2022 | |
| Mayne Pharma Commercial LLC | $36.93 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $32.90 | 2020-2021 | |
| Aspira Women'S Health INC | $30.89 | 2022-2024 | Ova1 |
| Baxter Healthcare | $29.56 | 2025 | Perclot |
| Roche Diagnostics Corporation | $29.08 | 2019 | |
| Exeltis, USA INC. | $27.22 | 2023-2025 | Slynd |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $24.47 | 2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $15.57 | 2023 | Veozah |
| Sage Therapeutics, LLC | $14.30 | 2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.